ArticleJournal of the American Chemical Society2025
Strategic Fermi Level Engineering of Donor-Acceptor Self-Assembled Monolayer toward Ultrahigh Paired-Pulse Facilitations in Photosynaptic Transistors.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the rapid advancement of artificial intelligence and the demand for low-power computing, photosynaptic transistors have emerged as promising candidates by integrating sensing, memory, and processing to mimic biological synapses. However, simultaneously realizing high paired-pulse facilitation (PPF) and low energy consumption in an artificial synapse, as biological ones, remains challenging. This property should be achieved by balancing the high carrier density while maintaining a low conductivity in the photoresponsive/charge-trapping electret; however, these prerequisites are mutually contradictory. To achieve this goal, a series of electron acceptors, 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.